Research Areas

In ths section, by  far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.

Items 31 to 45 of 1699 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Axon ID Name Description From price
2636 YJC-10592 CCR2 antagonist €145.00
1174 Y 700 Xanthine oxidase inhibitor €135.00
2911 Y 29794 tosylate Orally active, brain penetrant, potent and specific prolyl endopeptidase (PPCE) inhibitor €125.00
1683 Y 27632 dihydrochloride ROCK1 and ROCK2 inhibitor €65.00
1621 XMD 8-92 trifluoroacetate BMK1 inhibitor; ERK5 inhibitor €70.00
1846 XMD 8-92 BMK1 inhibitor; ERK5 inhibitor €70.00
2762 XMD 8-87 Potent and selective inhibitor of Ack1 tyrosine kinase (also known as TNK2) €95.00
1706 XL PI3K/mTOR inhibitor Dual PI3K and mTOR kinase inhibitor €125.00
2268 XL 413 hydrochloride Potent, selective and orally bioavailable CDC7 inhibitor €120.00
2951 XL 388 Highly potent, selective, ATP-competitive, and orally bioavailable mTOR inhibitor €125.00
2231 XL 019 JAK2 inhibitor €100.00
2056 XEN 907 Sodium channel blocker (voltage-gated Nav1.7) €135.00
1305 XE 991 dihydrochloride KCNQ channel and M-current blocker €90.00
1987 XE 991 KCNQ channel and M-current blocker €90.00
2337 XCT 790 ERRα inverse agonist and potent mitochondrial uncoupler €120.00

Items 31 to 45 of 1699 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Please wait...